Status:
COMPLETED
Prevention of Adolescent Risky Behaviors: Neural Markers of Intervention Effects
Lead Sponsor:
University of California, Irvine
Conditions:
Risk-Taking
Adolescent Behavior
Eligibility:
All Genders
11-14 years
Phase:
NA
Brief Summary
Adolescence is a time of biological and behavioral changes that can lead to risky and dangerous behaviors, and African-American youth are highly vulnerable to the consequences of risky behavior, inclu...
Detailed Description
Adolescence is a time of dramatic biological, behavioral and social changes. It is one of the healthiest periods of the life-span, yet morbidity and mortality rates increase 200%, often attributed to ...
Eligibility Criteria
Inclusion
- Subject is of African-American racial status (self-reported)
- Subject can speak and read English
- Subject and parent/legal guardian agree to participate in the 6-week PAAS program
- Subject and parent/legal guardian agree to complete all assessments
- Subject must meet MRI safety eligibility
Exclusion
- Subject has a major medical problem (e.g. neurological disorders)
- Subject is on medication(s) that affects the central nervous system
- Subject has behavioral/emotional problems at a clinical level (parent and/or youth report)
- Subject is pregnant or suspected of being pregnant (based on pregnancy test)
- Subject is color-blind
- Subject has claustrophobia
- Subject has metallic implants
- Subject drinks alcohol in the week prior to entry into the study (based on urine drug screen)
- Subject uses drugs in the week prior to entry into the study (based on urine drug screen)
Key Trial Info
Start Date :
December 11 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 10 2025
Estimated Enrollment :
146 Patients enrolled
Trial Details
Trial ID
NCT03370393
Start Date
December 11 2017
End Date
April 10 2025
Last Update
April 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, Irvine
Irvine, California, United States, 92617